Company news

Pliant Therapeutics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2022 Financial Results

May 8, 2022

Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Idiopathic Pulmonary Fibrosis

May 2, 2022

Pliant Therapeutics Announces Multiple Presentations at the 2022 American Thoracic Society International Conference

May 1, 2022

Pliant Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2021 Financial Results

February 27, 2022

Pliant Therapeutics Announces Positive Data from Expanded Phase 1b BAL Trial of PLN-74809 Demonstrated Suppression of TGF-β Signaling in Healthy Volunteers

February 27, 2022

Pliant Therapeutics Announces Positive DSMB Safety Review and Commencement of Enrollment of Phase 2a Trial of PLN-74809 at 320 mg Dose in Idiopathic Pulmonary Fibrosis

February 23, 2022

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2021 Financial Results

November 8, 2021

Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2021 Financial Results

August 8, 2021

Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2021 Financial Results

May 9, 2021

Pliant Therapeutics Announces Successful Completion of PLN-1474 Phase 1 Study and Development Transition to Global Pharmaceutical Partner

March 15, 2021

Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors

January 11, 2021

Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF

January 3, 2021

Pliant Therapeutics Provides Corporate Update and Reports Third Quarter 2020 Financial Results

November 9, 2020

Pliant Therapeutics Appoints Mike Ouimette as General Counsel

October 4, 2020

Pliant Therapeutics Provides Corporate Update and Announces Second-Quarter 2020 Financial Results

August 10, 2020

Pliant Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares

June 4, 2020

Pliant Therapeutics Announces Pricing of Initial Public Offering

June 1, 2020

← Newer news releases

Decks

The 5 newest of 9 decks. Every deck is listed under its year.